Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D. Krimmel‐Morrison, Rosa Ana Risques, Talayeh Ghezelayagh et al.|Gynecologic Oncology|2019Cited by 23
Uterine Lavage Identifies Cancer Mutations and Increased <i>TP53</i> Somatic Mutation Burden in Individuals with Ovarian CancerTalayeh Ghezelayagh, Rosa Ana Risques, Brendan F. Kohrn et al.|Cancer Research Communications|2022Cited by 11
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh Ghezelayagh, Rosa Ana Risques, Brendan F. Kohrn et al.|Oncogene|2024Cited by 5
Uterine lavage for the detection of ovarian cancer using an expanded gene panelTalayeh Ghezelayagh, Barbara M. Norquist, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 1
Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer riskTalayeh Ghezelayagh, Rosana Risques, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 0